Index reshuffle puts Molina Healthcare back in small cap territory

Molina Healthcare (MOH) has been dropped from the FTSE All-World Index and the S&P 500 Equal Weighted Index, while joining the Russell Small Cap Comp Growth and Value indices, a reshuffle that can influence index fund flows and trading patterns.

The latest index changes come at a time when momentum in Molina Healthcare's share price appears to be fading, with a 1 day share price return of a 2.0% decline and a year to date share price return of a 21.9% decline contributing to a 1 year total shareholder return of a 55.4% decline.

If this reshuffle has you rethinking where opportunity might sit in healthcare, it could be worth scanning for other names using our focused list of 36 healthcare AI stocks

With the share price under pressure, a value score of 5, an intrinsic value estimate suggesting a large discount and a modest gap to analyst targets, you have to ask: is this a reset opportunity, or is the market already looking through to future growth?

Most Popular Narrative: 66.1% Undervalued

According to the narrative on Molina Healthcare, a fair value of $411.65 is set against a last close of $139.41, a wide gap that frames a very different story to the recent share price slide.

Catalysts

• Membership Growth: MOH has seen a 9% increase in members year over year, reaching approximately 5.7 million members as of March 31, 2024. This growth is driven by new contract wins, acquisitions, and expansion.

Want to see how a fast expanding member base, rising premium revenue and Medicare expansion are stitched together into one valuation story? The key ingredients are growth assumptions on contracts, membership and margins that sit behind that $411.65 fair value, not the recent share price chart.

Result: Fair Value of $411.65 (UNDERVALUED)

However, this story can change quickly if regulatory shifts around Medicaid or higher than expected medical costs squeeze margins and challenge that undervalued thesis.

Next Steps

With sentiment split between sharp share price pressure and a wide fair value gap, it makes sense to review the data yourself, weigh both sides, and move quickly to shape your view by checking the 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Molina Healthcare has sharpened your focus, do not stop here. Broaden your watchlist with other ideas that match your style and risk comfort.

• Target dependable income by scanning companies that qualify as 13 dividend fortresses and see which payouts might suit a long term, cash focused approach.
• Hunt for quality at a discount by checking the 54 high quality undervalued stocks and compare how their fundamentals stack up against current prices.
• Prioritise resilience by reviewing the 72 resilient stocks with low risk scores so you are not missing companies that pair stability with measured risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.